US start-up Evvy launches vaginal healthcare platform

The US female-founded start-up Evvy has launched a vaginal healthcare platform to provide women with “physician-reviewed” results and prescription treatments.

The company has announced the expansion of its offerings after launching the first and only at-home metagenomics-based vaginal microbiome test in 2021.

Evvy will now be the first and only vaginal healthcare service to bring together testing, prescription treatments, and coaching.

Vaginal discomfort is one of the leading reasons women seek healthcare advice and over 90 per cent of these can be attributed to imbalances in the vaginal microbiome.

Yet current standards for vaginal health testing and care do not take into account the entire vaginal microbiome. Instead, vaginal healthcare is underpinned by overly simplistic methods like microscopy and brute-force antibiotics.

“The status quo in vaginal health is simply unacceptable given how prevalent these conditions are and how significantly they impact our quality of life,” said Priyanka Jain, CEO and co-founder of Evvy. 

“That’s why we decided to leverage our first-of-its-kind data platform and scientific advisory board to develop a new standard of care that women and people with vaginas can access from the comfort of their own home.”

Dr Rebecca Nelken, OB/GYN and founding physician at Evvy, said: “As an OB GYN, I know how frustrating it is for both patients and clinicians to lack access to effective testing and treatments.

“Evvy’s new care platform is revolutionary, and I am thrilled that patients across the country will finally have access to the best in class testing, holistic treatments, and empathetic support they deserve.”

Over the past year, the start-up ran an IRB-approved study to evaluate the efficacy of their new care platform. The study showed that 83 per cent of participants who went through the care platform moved from dysbiosis to a protective microbiome, and 100 per cent reported an improvement in symptoms.

Users can access clinical care with Evvy after taking the at-home vaginal health test, depending on their results and health history. A provider would then review the patient’s results, and if they are eligible, they are given a personalised treatment programme.

The Evvy vaginal health test is currently available in all 50 US states, and the new care platform is available in 39 US states with plans to expand to all 50 states this year.